| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | PIN_4 | 6.88e-07 | 4 | 105 | 3 | PF13638 | |
| Domain | Guanine_nucleotide-bd_bsu | 1.71e-06 | 5 | 105 | 3 | IPR016346 | |
| Domain | PIN_dom | 3.41e-06 | 6 | 105 | 3 | IPR002716 | |
| Domain | PINc | 3.41e-06 | 6 | 105 | 3 | SM00670 | |
| Domain | WD40_repeat_dom | 6.77e-06 | 297 | 105 | 10 | IPR017986 | |
| Domain | Gprotein_B | 2.01e-05 | 10 | 105 | 3 | IPR001632 | |
| Domain | COR | 3.13e-05 | 2 | 105 | 2 | IPR032171 | |
| Domain | COR | 3.13e-05 | 2 | 105 | 2 | PF16095 | |
| Domain | EGF_3 | 5.45e-05 | 235 | 105 | 8 | PS50026 | |
| Domain | EGF-like_dom | 8.17e-05 | 249 | 105 | 8 | IPR000742 | |
| Domain | Requiem/DPF_N_dom | 9.36e-05 | 3 | 105 | 2 | IPR025750 | |
| Domain | Requiem_N | 9.36e-05 | 3 | 105 | 2 | PF14051 | |
| Domain | FBN | 9.36e-05 | 3 | 105 | 2 | IPR011398 | |
| Domain | EGF-like_CS | 1.13e-04 | 261 | 105 | 8 | IPR013032 | |
| Domain | EGF_CA | 1.24e-04 | 86 | 105 | 5 | PF07645 | |
| Domain | EGF_2 | 1.26e-04 | 265 | 105 | 8 | PS01186 | |
| Domain | WD40 | 1.36e-04 | 268 | 105 | 8 | SM00320 | |
| Domain | WD40_repeat | 1.50e-04 | 272 | 105 | 8 | IPR001680 | |
| Domain | ROC_dom | 1.86e-04 | 4 | 105 | 2 | IPR020859 | |
| Domain | ROC | 1.86e-04 | 4 | 105 | 2 | PS51424 | |
| Domain | EGF_Ca-bd_CS | 2.18e-04 | 97 | 105 | 5 | IPR018097 | |
| Domain | EGF_CA | 2.40e-04 | 99 | 105 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.52e-04 | 100 | 105 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.30e-04 | 106 | 105 | 5 | IPR000152 | |
| Domain | EGF | 3.65e-04 | 235 | 105 | 7 | SM00181 | |
| Domain | cEGF | 4.09e-04 | 26 | 105 | 3 | PF12662 | |
| Domain | cEGF | 4.09e-04 | 26 | 105 | 3 | IPR026823 | |
| Domain | - | 5.84e-04 | 333 | 105 | 8 | 2.130.10.10 | |
| Domain | EGF_1 | 5.95e-04 | 255 | 105 | 7 | PS00022 | |
| Domain | WD40/YVTN_repeat-like_dom | 6.08e-04 | 335 | 105 | 8 | IPR015943 | |
| Domain | EGF_CA | 6.28e-04 | 122 | 105 | 5 | SM00179 | |
| Domain | TB | 6.45e-04 | 7 | 105 | 2 | PF00683 | |
| Domain | WD40 | 6.52e-04 | 259 | 105 | 7 | PF00400 | |
| Domain | EGF-like_Ca-bd_dom | 6.76e-04 | 124 | 105 | 5 | IPR001881 | |
| Domain | - | 8.57e-04 | 8 | 105 | 2 | 3.90.290.10 | |
| Domain | WD_REPEATS_1 | 9.87e-04 | 278 | 105 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.01e-03 | 279 | 105 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.01e-03 | 279 | 105 | 7 | PS50294 | |
| Domain | TB_dom | 1.10e-03 | 9 | 105 | 2 | IPR017878 | |
| Domain | TB | 1.10e-03 | 9 | 105 | 2 | PS51364 | |
| Domain | G-protein_beta_WD-40_rep | 1.35e-03 | 85 | 105 | 4 | IPR020472 | |
| Domain | LDLR_class-A_CS | 1.47e-03 | 40 | 105 | 3 | IPR023415 | |
| Domain | Growth_fac_rcpt_ | 1.88e-03 | 156 | 105 | 5 | IPR009030 | |
| Domain | - | 1.99e-03 | 12 | 105 | 2 | 3.40.50.1010 | |
| Domain | Ldl_recept_a | 2.06e-03 | 45 | 105 | 3 | PF00057 | |
| Domain | - | 2.20e-03 | 46 | 105 | 3 | 4.10.400.10 | |
| Domain | WD40_repeat_CS | 2.34e-03 | 164 | 105 | 5 | IPR019775 | |
| Domain | MIRO-like | 2.35e-03 | 13 | 105 | 2 | IPR013684 | |
| Domain | Roc | 2.35e-03 | 13 | 105 | 2 | PF08477 | |
| Domain | LDLRA_1 | 2.49e-03 | 48 | 105 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.64e-03 | 49 | 105 | 3 | IPR002172 | |
| Domain | LDLa | 2.64e-03 | 49 | 105 | 3 | SM00192 | |
| Domain | LDLRA_2 | 2.64e-03 | 49 | 105 | 3 | PS50068 | |
| Domain | PIN_domain-like | 2.73e-03 | 14 | 105 | 2 | IPR029060 | |
| Domain | Ldl_recept_b | 2.73e-03 | 14 | 105 | 2 | PF00058 | |
| Domain | LDLRB | 2.73e-03 | 14 | 105 | 2 | PS51120 | |
| Domain | ARM-type_fold | 3.04e-03 | 339 | 105 | 7 | IPR016024 | |
| Domain | LY | 3.13e-03 | 15 | 105 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.13e-03 | 15 | 105 | 2 | IPR000033 | |
| Domain | G_crystallin-rel | 4.52e-03 | 18 | 105 | 2 | IPR011024 | |
| Domain | EGF | 5.59e-03 | 126 | 105 | 4 | PF00008 | |
| Pathway | WP_RAS_SIGNALING | 4.15e-05 | 184 | 72 | 7 | M39764 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 1.17e-04 | 19 | 72 | 3 | MM15021 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 1.17e-04 | 19 | 72 | 3 | M926 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 1.37e-04 | 20 | 72 | 3 | MM15572 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 1.37e-04 | 20 | 72 | 3 | M27853 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 1.59e-04 | 21 | 72 | 3 | M27409 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 1.59e-04 | 21 | 72 | 3 | MM15159 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 1.83e-04 | 22 | 72 | 3 | MM15016 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 1.83e-04 | 22 | 72 | 3 | M841 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 2.10e-04 | 23 | 72 | 3 | MM15033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY | 2.10e-04 | 23 | 72 | 3 | M47549 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 2.39e-04 | 24 | 72 | 3 | M13115 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 2.39e-04 | 24 | 72 | 3 | MM15088 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 2.39e-04 | 24 | 72 | 3 | M18308 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 2.39e-04 | 24 | 72 | 3 | M47460 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 2.39e-04 | 24 | 72 | 3 | MM14794 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 2.71e-04 | 25 | 72 | 3 | MM15056 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 2.71e-04 | 25 | 72 | 3 | M811 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 2.71e-04 | 25 | 72 | 3 | M14301 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 3.05e-04 | 26 | 72 | 3 | MM15017 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 3.05e-04 | 26 | 72 | 3 | M47561 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 3.05e-04 | 26 | 72 | 3 | M47562 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 3.05e-04 | 26 | 72 | 3 | M47557 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 3.05e-04 | 26 | 72 | 3 | M47456 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY | 3.42e-04 | 27 | 72 | 3 | M47454 | |
| Pathway | REACTOME_GPER1_SIGNALING | 3.42e-04 | 27 | 72 | 3 | MM15664 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 3.82e-04 | 28 | 72 | 3 | M10679 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY | 4.24e-04 | 29 | 72 | 3 | M47466 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 4.69e-04 | 71 | 72 | 4 | MM15590 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 4.70e-04 | 30 | 72 | 3 | M18193 | |
| Pathway | REACTOME_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS | 4.70e-04 | 30 | 72 | 3 | MM14542 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 5.18e-04 | 31 | 72 | 3 | MM15094 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 5.18e-04 | 31 | 72 | 3 | M47554 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY | 5.18e-04 | 31 | 72 | 3 | M47455 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY | 5.18e-04 | 31 | 72 | 3 | M47459 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 5.18e-04 | 31 | 72 | 3 | M47540 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 5.18e-04 | 31 | 72 | 3 | M47541 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 5.70e-04 | 32 | 72 | 3 | M861 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 5.70e-04 | 32 | 72 | 3 | M14309 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 5.70e-04 | 32 | 72 | 3 | MM15148 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 5.70e-04 | 32 | 72 | 3 | MM15143 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY | 5.70e-04 | 32 | 72 | 3 | M47962 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 5.70e-04 | 32 | 72 | 3 | MM14983 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 5.78e-04 | 75 | 72 | 4 | M27874 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 6.08e-04 | 76 | 72 | 4 | MM15051 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 6.24e-04 | 33 | 72 | 3 | MM15027 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 6.24e-04 | 33 | 72 | 3 | MM15020 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 6.24e-04 | 33 | 72 | 3 | MM15058 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY | 6.24e-04 | 33 | 72 | 3 | M47550 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 6.24e-04 | 33 | 72 | 3 | MM15066 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 6.24e-04 | 33 | 72 | 3 | M10322 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 6.24e-04 | 33 | 72 | 3 | M9379 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 6.24e-04 | 33 | 72 | 3 | M11575 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 7.44e-04 | 35 | 72 | 3 | M1075 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 8.08e-04 | 36 | 72 | 3 | MM14544 | |
| Pathway | REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING | 9.48e-04 | 38 | 72 | 3 | M27656 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 9.69e-04 | 86 | 72 | 4 | M916 | |
| Pathway | REACTOME_CHAPERONIN_MEDIATED_PROTEIN_FOLDING | 1.02e-03 | 39 | 72 | 3 | MM15003 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 1.10e-03 | 40 | 72 | 3 | MM15115 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.27e-03 | 42 | 72 | 3 | M791 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.36e-03 | 43 | 72 | 3 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.36e-03 | 43 | 72 | 3 | M933 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.36e-03 | 43 | 72 | 3 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.46e-03 | 44 | 72 | 3 | MM15709 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.55e-03 | 45 | 72 | 3 | MM15040 | |
| Pathway | REACTOME_GPER1_SIGNALING | 1.55e-03 | 45 | 72 | 3 | M45008 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.57e-03 | 98 | 72 | 4 | M776 | |
| Pathway | REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION | 1.64e-03 | 12 | 72 | 2 | MM15036 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 1.87e-03 | 48 | 72 | 3 | M10775 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 2.36e-03 | 52 | 72 | 3 | M920 | |
| Pathway | KEGG_ONE_CARBON_POOL_BY_FOLATE | 3.33e-03 | 17 | 72 | 2 | M12039 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 3.55e-03 | 60 | 72 | 3 | MM15708 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 3.55e-03 | 60 | 72 | 3 | MM14964 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 3.55e-03 | 60 | 72 | 3 | M976 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 3.59e-03 | 123 | 72 | 4 | MM14988 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 3.72e-03 | 61 | 72 | 3 | MM15071 | |
| Pathway | REACTOME_CA2_PATHWAY | 3.89e-03 | 62 | 72 | 3 | M27321 | |
| Pubmed | Genomic organization of the murine G protein beta subunit genes and related processed pseudogenes. | 2.75e-08 | 3 | 106 | 3 | 11913780 | |
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 1543505 | ||
| Pubmed | The role of G protein beta subunits in the release of ATP from human erythrocytes. | 1.10e-07 | 4 | 106 | 3 | 12512701 | |
| Pubmed | The cationic region of Rhes mediates its interactions with specific Gbeta subunits. | 1.10e-07 | 4 | 106 | 3 | 19255495 | |
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 16884933 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 9789084 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 24462769 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 2328987 | ||
| Pubmed | MYT1L SPTBN2 PEG3 ADGRB3 SESN3 SMG5 FTCD LRP1B CBR3 CCDC85A STAT6 KANSL2 FBN1 CLTC GNB1 ARHGAP21 | 1.78e-06 | 1285 | 106 | 16 | 35914814 | |
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 10339615 | ||
| Pubmed | Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex. | 3.25e-06 | 10 | 106 | 3 | 28334111 | |
| Pubmed | 3.25e-06 | 10 | 106 | 3 | 9733924 | ||
| Pubmed | 4.46e-06 | 11 | 106 | 3 | 10644457 | ||
| Pubmed | A Non-Canonical Function of Gβ as a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation. | 4.46e-06 | 11 | 106 | 3 | 25982117 | |
| Pubmed | Neural tube defects and impaired neural progenitor cell proliferation in Gbeta1-deficient mice. | 5.93e-06 | 12 | 106 | 3 | 20186915 | |
| Pubmed | Differential sensitivity of P-Rex1 to isoforms of G protein betagamma dimers. | 5.93e-06 | 12 | 106 | 3 | 16301321 | |
| Pubmed | 5.93e-06 | 12 | 106 | 3 | 8636150 | ||
| Pubmed | 6.12e-06 | 225 | 106 | 7 | 12168954 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18272292 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20525682 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 35534227 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17394548 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19122171 | ||
| Pubmed | Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions? | 9.20e-06 | 2 | 106 | 2 | 22988872 | |
| Pubmed | Genetic Analysis of LRRK1 and LRRK2 Variants in Essential Tremor Patients. | 9.20e-06 | 2 | 106 | 2 | 29812962 | |
| Pubmed | Dynamic and redundant regulation of LRRK2 and LRRK1 expression. | 9.20e-06 | 2 | 106 | 2 | 18045479 | |
| Pubmed | Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease. | 9.20e-06 | 2 | 106 | 2 | 20144646 | |
| Pubmed | Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease. | 9.20e-06 | 2 | 106 | 2 | 17225181 | |
| Pubmed | Variants in the LRRK1 gene and susceptibility to Parkinson's disease in Norway. | 9.20e-06 | 2 | 106 | 2 | 17324517 | |
| Pubmed | Cerd4, third member of the d4 gene family: expression and organization of genomic locus. | 9.20e-06 | 2 | 106 | 2 | 11845289 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15221638 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 1979057 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 33459343 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29056298 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29430464 | ||
| Pubmed | Expression of leucine-rich-repeat-kinase 2 (LRRK2) during embryonic development. | 9.20e-06 | 2 | 106 | 2 | 20403420 | |
| Pubmed | 9.77e-06 | 14 | 106 | 3 | 19168127 | ||
| Pubmed | 1.22e-05 | 15 | 106 | 3 | 12486123 | ||
| Pubmed | 1.81e-05 | 17 | 106 | 3 | 19376773 | ||
| Pubmed | 2.23e-05 | 497 | 106 | 9 | 23414517 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18765789 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8812431 | ||
| Pubmed | Mutations in G protein β subunits promote transformation and kinase inhibitor resistance. | 2.76e-05 | 3 | 106 | 2 | 25485910 | |
| Pubmed | Defective STAT signaling by the leptin receptor in diabetic mice. | 2.76e-05 | 3 | 106 | 2 | 8692797 | |
| Pubmed | Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue. | 2.76e-05 | 3 | 106 | 2 | 20422702 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 29735704 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 22952686 | ||
| Pubmed | Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment. | 2.76e-05 | 3 | 106 | 2 | 19712061 | |
| Pubmed | Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. | 2.76e-05 | 3 | 106 | 2 | 27322543 | |
| Pubmed | G protein beta gamma subunits. Simplified purification and properties of novel isoforms. | 2.76e-05 | 3 | 106 | 2 | 8308009 | |
| Pubmed | Elevation of LncRNA ENST00000453774.1 Prevents Renal Fibrosis by Upregulating FBN1, IGF1R, and KLF7. | 2.76e-05 | 3 | 106 | 2 | 34614499 | |
| Pubmed | Neurodegenerative phenotypes in an A53T α-synuclein transgenic mouse model are independent of LRRK2. | 2.76e-05 | 3 | 106 | 2 | 22357653 | |
| Pubmed | ETAA1 acts at stalled replication forks to maintain genome integrity. | 3.52e-05 | 21 | 106 | 3 | 27723720 | |
| Pubmed | 3.62e-05 | 529 | 106 | 9 | 14621295 | ||
| Pubmed | Protein phosphatase 1α interacting proteins in the human brain. | 5.39e-05 | 67 | 106 | 4 | 22321011 | |
| Pubmed | Mdm2-mediated ubiquitination of PKCβII in the nucleus mediates clathrin-mediated endocytic activity. | 5.50e-05 | 4 | 106 | 2 | 31634457 | |
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 5.50e-05 | 4 | 106 | 2 | 25034023 | |
| Pubmed | Bach2-Batf interactions control Th2-type immune response by regulating the IL-4 amplification loop. | 5.50e-05 | 4 | 106 | 2 | 27581382 | |
| Pubmed | A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice. | 5.50e-05 | 4 | 106 | 2 | 10486156 | |
| Pubmed | Interleukin-13 induces mucin 5AC production involving STAT6/SPDEF in human airway epithelial cells. | 5.50e-05 | 4 | 106 | 2 | 21275604 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 23526378 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 9503014 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 25093805 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 29106398 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 15955845 | ||
| Pubmed | AHCTF1 SPTBN2 PEG3 SHMT2 WDR76 DNTTIP1 CDK13 TLN1 CLTC GNB1 MUC5AC HSPA14 ZNF574 DCAF7 | 7.33e-05 | 1371 | 106 | 14 | 36244648 | |
| Pubmed | CTTNBP2 ADAMTS2 ZSWIM5 BACH2 LRRK2 SHMT2 WDR76 DMXL1 IGF1R LTN1 USP35 HSPA14 FBN3 | 8.50e-05 | 1215 | 106 | 13 | 15146197 | |
| Pubmed | 8.53e-05 | 28 | 106 | 3 | 8858601 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SPTBN2 INTS1 AMER3 FBXL7 TLN1 CLTC PKHD1 LRRC7 ARHGAP20 FBN3 | 8.70e-05 | 736 | 106 | 10 | 29676528 |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 8550614 | ||
| Pubmed | Localization of the gene for a third G protein beta-subunit to mouse chromosome 6 near Raf-1. | 9.15e-05 | 5 | 106 | 2 | 1572642 | |
| Pubmed | Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. | 9.15e-05 | 5 | 106 | 2 | 18840781 | |
| Pubmed | Depletion of CUL4B in macrophages ameliorates diabetic kidney disease via miR-194-5p/ITGA9 axis. | 9.15e-05 | 5 | 106 | 2 | 37224018 | |
| Pubmed | Molecular basis for recognition of Gly/N-degrons by CRL2ZYG11B and CRL2ZER1. | 9.15e-05 | 5 | 106 | 2 | 34214466 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 18172297 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 7649993 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 24046356 | ||
| Pubmed | Reduced oxidative capacity in macrophages results in systemic insulin resistance. | 9.15e-05 | 5 | 106 | 2 | 29674655 | |
| Pubmed | 9.66e-05 | 149 | 106 | 5 | 22664934 | ||
| Pubmed | 1.05e-04 | 30 | 106 | 3 | 31043422 | ||
| Pubmed | 1.09e-04 | 153 | 106 | 5 | 10718198 | ||
| Pubmed | 1.16e-04 | 31 | 106 | 3 | 12626323 | ||
| Pubmed | MYT1L CAND2 AHCTF1 PEG3 SHMT2 ITGA9 DIS3 STAT6 SCML2 CLTC LTN1 ARHGAP21 | 1.18e-04 | 1084 | 106 | 12 | 11544199 | |
| Pubmed | 1.24e-04 | 251 | 106 | 6 | 27507650 | ||
| Pubmed | 1.28e-04 | 32 | 106 | 3 | 23704327 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 16371464 | ||
| Pubmed | ATR-ATRIP kinase complex triggers activation of the Fanconi anemia DNA repair pathway. | 1.37e-04 | 6 | 106 | 2 | 22258451 | |
| Pubmed | Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice. | 1.37e-04 | 6 | 106 | 2 | 23675505 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 18286479 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 7665596 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 9238069 | ||
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 10570481 | ||
| Pubmed | 2.15e-04 | 38 | 106 | 3 | 28218735 | ||
| Pubmed | Novel Cul3 binding proteins function to remodel E3 ligase complexes. | 2.50e-04 | 40 | 106 | 3 | 25011449 | |
| Pubmed | 2.55e-04 | 8 | 106 | 2 | 18249219 | ||
| Pubmed | 2.57e-04 | 407 | 106 | 7 | 12693553 | ||
| Pubmed | 3.27e-04 | 9 | 106 | 2 | 22899650 | ||
| Pubmed | Insulin resistance and diabetes caused by genetic or diet-induced KBTBD2 deficiency in mice. | 3.27e-04 | 9 | 106 | 2 | 27708159 | |
| Pubmed | 3.27e-04 | 9 | 106 | 2 | 22976293 | ||
| Pubmed | Ataxin 10 induces neuritogenesis via interaction with G-protein beta2 subunit. | 3.27e-04 | 9 | 106 | 2 | 16498633 | |
| GeneFamily | WD repeat domain containing | 8.93e-05 | 262 | 73 | 7 | 362 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.62e-07 | 179 | 107 | 7 | 5be883d7d0be3180bb9844e4a757f0dd247294e4 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.00e-06 | 137 | 107 | 6 | 6d90da42dcc06aa895f920218055068f3c76d57d | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.39e-06 | 169 | 107 | 6 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-06 | 169 | 107 | 6 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | mild_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 3.51e-06 | 170 | 107 | 6 | 85c476e0bc496445e868a88849960598d97bdea2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.03e-06 | 181 | 107 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | COVID-19_Moderate-HSPC|World / disease group, cell group and cell class | 5.53e-06 | 184 | 107 | 6 | ccc93babe1fcdeb66b78e1d8414357877a7c45bd | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.71e-06 | 185 | 107 | 6 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.89e-06 | 186 | 107 | 6 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | Healthy-HSPC|World / disease group, cell group and cell class | 6.07e-06 | 187 | 107 | 6 | 8cd9e5499e5c2b2321ecbcf780df37fe0f165ac9 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 189 | 107 | 6 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 189 | 107 | 6 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 189 | 107 | 6 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-06 | 193 | 107 | 6 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.27e-06 | 193 | 107 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.49e-06 | 194 | 107 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.71e-06 | 195 | 107 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.02e-05 | 137 | 107 | 5 | 25b5370b63644351efddb8749ef174beca0581cd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 144 | 107 | 5 | cc11cce43d1af8ac63140d05faf215ae9a10cde1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-05 | 154 | 107 | 5 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-05 | 154 | 107 | 5 | ade094e2947761a0a34daa8fcff3e9ea8437e4a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-05 | 154 | 107 | 5 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-05 | 154 | 107 | 5 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 157 | 107 | 5 | b527e88382c8d21188a0f222b3302523e8816dfc | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.99e-05 | 158 | 107 | 5 | 0d4fe87fc7901dd5f9c004e91708a03cafdb4ad9 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.50e-05 | 162 | 107 | 5 | e73c644ce1db34f1d390878954e86fa0b3a455a1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-05 | 165 | 107 | 5 | 6a621b300442c52adfc15b61d3a6d3a3cb00099f | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 4.91e-05 | 165 | 107 | 5 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.05e-05 | 166 | 107 | 5 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 5.05e-05 | 166 | 107 | 5 | a853005a5587d42daecdf2e23a93109919021a4f | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.35e-05 | 168 | 107 | 5 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.50e-05 | 169 | 107 | 5 | da3485d77bb7876fad4f166f6099e681b27457ae | |
| ToppCell | 3'_v3-blood-Hematopoietic_progenitors-HSC-MPP|blood / Manually curated celltypes from each tissue | 5.65e-05 | 170 | 107 | 5 | 1443d7fccc81088dd42dcbb9361e269872542274 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.98e-05 | 172 | 107 | 5 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 5.98e-05 | 172 | 107 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | severe_COVID-19-HSPC|severe_COVID-19 / disease group, cell group and cell class (v2) | 6.31e-05 | 174 | 107 | 5 | 6d35bacf073537b272ff821e604c899fb9ce6a7c | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_MEMP|lymph-node_spleen / Manually curated celltypes from each tissue | 6.66e-05 | 176 | 107 | 5 | 23a8ec42ebd42c539865a12d09773af90f3f8848 | |
| ToppCell | 3'_v3-blood-Hematopoietic_progenitors|blood / Manually curated celltypes from each tissue | 6.84e-05 | 177 | 107 | 5 | 22c77077951889e63489abfabf90900655655c82 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.84e-05 | 177 | 107 | 5 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | severe_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 6.84e-05 | 177 | 107 | 5 | 289f6aed6f054b04b01659434d8c8b467d1bf5dd | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 7.22e-05 | 179 | 107 | 5 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.22e-05 | 179 | 107 | 5 | 4bb2debfc9e9f258cd38e797ef160bd440aad6af | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.22e-05 | 179 | 107 | 5 | 2f690f933bf6b99abeb31766e0b22bdbe36c1ba0 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.22e-05 | 179 | 107 | 5 | 3e2c937369b8190fd5d5a31689d029e6e89fb5e2 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 7.22e-05 | 179 | 107 | 5 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.41e-05 | 180 | 107 | 5 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-05 | 181 | 107 | 5 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.61e-05 | 181 | 107 | 5 | e7f7b519c2a01c15f26df11ec9b434c0d1630c7a | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.61e-05 | 181 | 107 | 5 | 54a19cf6a3b752e2391feb8b316bebee0e602d17 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.61e-05 | 181 | 107 | 5 | 5b84625b1d3737708001b64f6da9360330d39a27 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.81e-05 | 182 | 107 | 5 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 7.81e-05 | 182 | 107 | 5 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 7.81e-05 | 182 | 107 | 5 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.81e-05 | 182 | 107 | 5 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.81e-05 | 182 | 107 | 5 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.81e-05 | 182 | 107 | 5 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.81e-05 | 182 | 107 | 5 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.81e-05 | 182 | 107 | 5 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.81e-05 | 182 | 107 | 5 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.22e-05 | 184 | 107 | 5 | 51d0447699e3b8f01abbde83f26b748bc9f3c723 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.22e-05 | 184 | 107 | 5 | f7b0bb45a9055ab34e98b251217f6ec38c75ca22 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.22e-05 | 184 | 107 | 5 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.22e-05 | 184 | 107 | 5 | 26edbf84216538b80f1ffcc079ee6e385a71fbf9 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-05 | 185 | 107 | 5 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-05 | 185 | 107 | 5 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-05 | 185 | 107 | 5 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-05 | 185 | 107 | 5 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-05 | 185 | 107 | 5 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | COVID-19_Moderate-HSPC|COVID-19_Moderate / disease group, cell group and cell class | 8.43e-05 | 185 | 107 | 5 | cacc6ab5f26f6c803894567fb838ea06eaa7efe5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-05 | 186 | 107 | 5 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-05 | 186 | 107 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.65e-05 | 186 | 107 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-05 | 186 | 107 | 5 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 8.87e-05 | 187 | 107 | 5 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.87e-05 | 187 | 107 | 5 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.09e-05 | 188 | 107 | 5 | 013162466a3334b6967c0cb670c8577d809b1396 | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.09e-05 | 188 | 107 | 5 | be25371e6459504b5f0c9ece3a0fe8f80c7824ca | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-05 | 188 | 107 | 5 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.32e-05 | 189 | 107 | 5 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 9.32e-05 | 189 | 107 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 9.32e-05 | 189 | 107 | 5 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | Healthy-HSPC|Healthy / disease group, cell group and cell class | 9.32e-05 | 189 | 107 | 5 | 214b225effc40ca1b83dd8052f2a7b80b65d4938 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.80e-05 | 191 | 107 | 5 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-05 | 191 | 107 | 5 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.80e-05 | 191 | 107 | 5 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 9.80e-05 | 191 | 107 | 5 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-05 | 191 | 107 | 5 | d1205aab0937f2becfcd239610e9b78fb8a0c886 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 192 | 107 | 5 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-04 | 192 | 107 | 5 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CFuPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.00e-04 | 192 | 107 | 5 | a8841ebd879f1c344ab4246fdef77044170f644d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 192 | 107 | 5 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 192 | 107 | 5 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-04 | 193 | 107 | 5 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 193 | 107 | 5 | 088c8b1e968f5356502347eaabdc6b1b1d4befd0 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 1.03e-04 | 193 | 107 | 5 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 193 | 107 | 5 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|World / Lineage, cell class and subclass | 1.05e-04 | 194 | 107 | 5 | f054d78429364622d402ce1d9bf6ad13a1a1bf7e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-04 | 194 | 107 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-04 | 194 | 107 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 194 | 107 | 5 | a7bfc535546d3c1a4e0cbcfeb7da816b34303350 | |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 3.69e-06 | 195 | 106 | 8 | 6415_UP | |
| Disease | connective tissue disease (implicated_via_orthology) | 3.47e-05 | 3 | 101 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | cortical thickness | CTTNBP2 ADAMTS2 SPTBN2 TG IGF1R FBN1 FBXL7 MALRD1 UMODL1 PKHD1 USP35 ARHGAP21 PLCE1 | 1.10e-04 | 1113 | 101 | 13 | EFO_0004840 |
| Disease | osteopetrosis (implicated_via_orthology) | 2.41e-04 | 7 | 101 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | descending aortic diameter | 2.42e-04 | 88 | 101 | 4 | EFO_0021788 | |
| Disease | Alzheimer disease | 2.67e-04 | 485 | 101 | 8 | MONDO_0004975 | |
| Disease | Developmental delay (disorder) | 2.78e-04 | 37 | 101 | 3 | C0424605 | |
| Disease | waist-hip ratio | KNTC1 CAND2 ADAMTS2 ZNF407 CYTL1 KBTBD2 ITGA9 MYLK2 IGF1R ALG9 ATP2A1 ARHGAP21 PLCE1 | 2.83e-04 | 1226 | 101 | 13 | EFO_0004343 |
| Disease | corpus callosum volume measurement | 3.94e-04 | 100 | 101 | 4 | EFO_0010299 | |
| Disease | central corneal thickness | 6.92e-04 | 309 | 101 | 6 | EFO_0005213 | |
| Disease | lung adenocarcinoma, family history of lung cancer | 7.19e-04 | 51 | 101 | 3 | EFO_0000571, EFO_0006953 | |
| Disease | cesarean section, intelligence | 7.49e-04 | 12 | 101 | 2 | EFO_0004337, EFO_0009636 | |
| Disease | idiopathic osteonecrosis of the femoral head | 7.62e-04 | 52 | 101 | 3 | EFO_1001930 | |
| Disease | prostate carcinoma (is_implicated_in) | 8.83e-04 | 13 | 101 | 2 | DOID:10286 (is_implicated_in) | |
| Disease | lysophosphatidylcholine 15:0 measurement | 1.03e-03 | 14 | 101 | 2 | EFO_0020941 | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.10e-03 | 59 | 101 | 3 | EFO_0009658, GO_0009410 | |
| Disease | Global developmental delay | 1.15e-03 | 133 | 101 | 4 | C0557874 | |
| Disease | serum gamma-glutamyl transferase measurement | ZSWIM5 ITGA9 VMO1 IGF1R TLN1 RP1L1 PKHD1 ZER1 ARHGAP21 PLCE1 | 1.17e-03 | 914 | 101 | 10 | EFO_0004532 |
| Disease | quinate measurement | 1.18e-03 | 15 | 101 | 2 | EFO_0021167 | |
| Disease | Graves' disease (is_marker_for) | 1.18e-03 | 15 | 101 | 2 | DOID:12361 (is_marker_for) | |
| Disease | risk-taking behaviour | 1.25e-03 | 764 | 101 | 9 | EFO_0008579 | |
| Disease | Inborn Errors of Metabolism | 1.53e-03 | 17 | 101 | 2 | C0025521 | |
| Disease | renal fibrosis (implicated_via_orthology) | 1.53e-03 | 17 | 101 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | platelet crit | 1.58e-03 | 952 | 101 | 10 | EFO_0007985 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.70e-03 | 148 | 101 | 4 | C0279702 | |
| Disease | glaucoma | 1.97e-03 | 154 | 101 | 4 | MONDO_0005041 | |
| Disease | Paroxysmal atrial fibrillation | 2.06e-03 | 156 | 101 | 4 | C0235480 | |
| Disease | prostate cancer (is_marker_for) | 2.06e-03 | 156 | 101 | 4 | DOID:10283 (is_marker_for) | |
| Disease | familial atrial fibrillation | 2.06e-03 | 156 | 101 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.06e-03 | 156 | 101 | 4 | C2585653 | |
| Disease | behavioural disinhibition measurement | 2.20e-03 | 75 | 101 | 3 | EFO_0006946 | |
| Disease | Atrial Fibrillation | 2.26e-03 | 160 | 101 | 4 | C0004238 | |
| Disease | Ovarian Serous Adenocarcinoma | 2.80e-03 | 23 | 101 | 2 | C1335177 | |
| Disease | Immunologic Deficiency Syndromes | 2.80e-03 | 23 | 101 | 2 | C0021051 | |
| Disease | sudden cardiac arrest | 2.93e-03 | 83 | 101 | 3 | EFO_0004278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EELNACSGRELCANL | 271 | Q5DID0 | |
| CRALCEDVASLQSFD | 231 | Q8N944 | |
| ELLDNFSCLSQEVCR | 701 | Q9BYV9 | |
| CLCDRLSTFAILAQQ | 851 | O60242 | |
| CAALLSNISDCDETF | 71 | Q9H6U8 | |
| DSLNLDEFCNCSEHI | 121 | P41180 | |
| IDSCIQSFDADGNLC | 66 | O95267 | |
| FSELCSLTECLQDEQ | 556 | Q8IYT2 | |
| QLRADDCFCASRKLD | 546 | A6QL63 | |
| AQLHCCDEEISFSLR | 791 | Q008S8 | |
| LFNDCGALESSQLCD | 401 | P51793 | |
| DLDECTSRQHNCQFL | 2446 | Q75N90 | |
| EVIALQRTCDFCSDA | 2066 | Q9Y485 | |
| RCTAEQALQCEFLRD | 986 | Q14004 | |
| DDFVEDLLCCLNLNS | 166 | Q8TCP9 | |
| RLECLLNNNKNSDFC | 106 | P61962 | |
| ICALCNDSSLDFNEA | 416 | O14983 | |
| DFQLCSRQDCPDSLA | 606 | O95450 | |
| DRCSALLELQRFNLC | 146 | A0A1B0GUU1 | |
| DCCLLTFSVDDRQSF | 81 | Q9NP90 | |
| RQCRGLELIASENFC | 66 | P34897 | |
| VNLADCLCNEDLESR | 746 | O94822 | |
| GNICRADEFLCNNSL | 3671 | Q9NZR2 | |
| DICTNLCEALQNFFS | 36 | Q8TC57 | |
| ATIRNDFLCNLCASS | 176 | Q4G0Z9 | |
| DFLCNLCASSLQEDR | 181 | Q4G0Z9 | |
| EECCRNLAFSLALRS | 2096 | Q8N201 | |
| GNLSLLEEFDCSCNE | 296 | Q96NW7 | |
| RDLLEEACDQCASQL | 71 | Q38SD2 | |
| LCGTSENDDQLLFCD | 321 | Q92784 | |
| CINFDFNTIRCQDLS | 206 | Q7Z5Y7 | |
| KDCLQNSLCEAEDRF | 341 | O76015 | |
| CVDRDFCANILSAES | 276 | P08069 | |
| GQALCLTAREEDCFQ | 241 | Q9H1R3 | |
| ENCVRLLSFADLFSC | 131 | Q8IY47 | |
| ANELRDIDALSQKCC | 991 | Q5S007 | |
| FRSEQDRNCSLCADN | 91 | P48357 | |
| CSTFQLDCDAVLQLF | 1451 | P50748 | |
| LSCCRFLDDNQIITS | 146 | P62879 | |
| LSCCRFLDDNNIVTS | 146 | P16520 | |
| CRQDLCFCEDTDLLS | 291 | P98088 | |
| CLANLASRCGLQDDF | 96 | Q96KJ4 | |
| FCRRDLVFLLDDCNA | 106 | Q9NRR1 | |
| CDVCGQLFNDRLSLA | 1566 | Q9GZU2 | |
| ANTDNCSLKDLVREC | 166 | Q96F15 | |
| RNECKLSDQRAALSC | 491 | Q3MJ16 | |
| FERNCRSEDCAADLQ | 616 | Q13797 | |
| RFDATDEELRLCQAC | 256 | Q5VYJ5 | |
| TEDCSCLQDRFRFNE | 106 | P07320 | |
| DIACDSQRCRILQAF | 106 | O43497 | |
| LSCCRFLDDNQIVTS | 146 | P62873 | |
| SDDLECENTICALNI | 986 | Q8WZ74 | |
| SDTGLECLALNCFNL | 416 | Q9UJT9 | |
| TCTDLDECSENLNLC | 1401 | P35555 | |
| AARCLLEQVQACFSR | 81 | Q92506 | |
| DNQELRDLCCFLDDD | 101 | Q96PX6 | |
| SQDLSCDFCNDVLAR | 171 | Q8N1E2 | |
| TDNRTCRVECSDNLF | 176 | P48740 | |
| LQCLRAFENCSEDLQ | 141 | O75828 | |
| RCLAFVDDVRCSNQS | 301 | Q9H9L4 | |
| LLVDLCLDDLSCNQN | 166 | Q8WYP5 | |
| LAENTSCDFLPRFQC | 571 | Q8WXE1 | |
| DIASENSISRLLFCC | 521 | Q96DZ5 | |
| FCNLDDDELRESCLQ | 266 | O75155 | |
| FIAFRRQDCDLINDC | 741 | Q8NG08 | |
| QELARCGNLACRSDL | 466 | O95954 | |
| DEDSFRNCLLSCERL | 106 | Q9BXW9 | |
| FDCNVSRARFELLCS | 291 | Q0VDF9 | |
| CDTRENASDISCFQL | 566 | Q9P2F6 | |
| ECSLDCHRAELSQLF | 226 | Q15542 | |
| ICDLDTQFRCQESGT | 1116 | Q92673 | |
| LALENRCQFCELSAA | 141 | Q9H628 | |
| RCQFCELSAAEQSLE | 146 | Q9H628 | |
| SLCQSVLEDFNLCLF | 311 | Q9UPR3 | |
| LEVDHFSCCNSDLQD | 86 | Q17RD7 | |
| DRENDLFLCDTNTCK | 61 | Q9UIK5 | |
| FCTLSENLILDDCGN | 201 | Q9P212 | |
| ASDSQCQAFCLLEAA | 586 | Q5VXU9 | |
| LGDDTALNDARLFCC | 186 | Q7Z5L0 | |
| NFDLINCVAIRTCSD | 2476 | P08F94 | |
| CSFVILCTDDRNLRN | 501 | Q5T5J6 | |
| SNLCSLKCDVDRLAF | 546 | Q9Y2L1 | |
| NQRCLCSAESLLDYG | 171 | O43610 | |
| CDLELINVCNENSLF | 926 | Q00610 | |
| LLCDFLDSQDSGSLC | 476 | Q9HA65 | |
| CLFLTLTEACRLNDD | 611 | Q9P217 | |
| CKECASFSSLENLQR | 171 | Q8N8Z8 | |
| ALCTDFCLRNLDGTL | 11 | Q7Z7L7 | |
| ERLCESNDQCGEALS | 111 | Q8NEP9 | |
| DANRAELFAQSCCAL | 1381 | O15020 | |
| FLNARACACATNEDE | 1261 | Q8IWN7 | |
| EACRSCLEQAKLLFS | 116 | Q9H147 | |
| LRFLENFCHSLQCDN | 446 | Q9UQR0 | |
| LISVNNFCVCDLAND | 226 | P58005 | |
| CETAIAALNSCLRDL | 1661 | Q9Y490 | |
| DAFCCNLASALLSDT | 46 | P42226 | |
| LCCLNVSSREEAFTD | 581 | Q9P2H5 | |
| TQELFCSACDQLFLS | 306 | Q6ZN55 | |
| DELERSFDCCGLFNL | 121 | Q12999 | |
| AINSDLCCSSQDLEF | 136 | O95685 | |
| NICGTSENDDQLLFC | 331 | Q92785 | |
| SENDDQLLFCDDCDR | 336 | Q92785 | |
| ADCNLRIFDSSCISS | 516 | Q9H967 | |
| QCCSFISLDEINLRD | 591 | Q9C0G0 | |
| ASSDAICRDFLRNVC | 36 | Q96K80 | |
| LTTSDCECLFQAEDR | 1011 | Q5T5U3 | |
| SNFSAVRDLCLSECS | 2121 | P01266 | |
| ECKQCDQAFSRLSSL | 391 | Q96BR6 | |
| ALENCASLLCIRADE | 631 | Q8NEV4 | |
| DQALAERCLAALTEC | 526 | P22033 | |
| EVCLSSLECLRNQCF | 321 | Q9UL68 |